Effects of platelet-activating factor, thromboxane A2 and leukotriene D4 on isolated perfused rat liver

Prostaglandins and Other Lipid Mediators

Volumn 80, Issue 1-2, 2006, Pages 35-45

  Cui, Sen ^a   Shibamoto, Toshishige ^a   Liu, Wei ^a   Takano, Hiromichi ^a   Kurata, Yasutaka ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatic circulation; LTD4; Microcirculation; Oxygen consumption; PAF; Sinusoidal pressure; The double occlusion pressure; U 46619

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; LEUKOTRIENE D4; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; THROMBOXANE A2 DERIVATIVE; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ISOLATED LIVER; LIVER BLOOD VESSEL; LIVER CIRCULATION; LIVER METABOLISM; LIVER PERFUSION; LIVER SINUSOID; LIVER VEIN; LIVER WEIGHT; MALE; MICROCIRCULATION; NONHUMAN; OXYGEN CONSUMPTION; RAT; VASCULAR RESISTANCE; VENOCONSTRICTION; WEIGHT GAIN; WEIGHT REDUCTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; HEMODYNAMIC PROCESSES; LEUKOTRIENE D4; LIVER; MALE; ORGAN SIZE; OXYGEN CONSUMPTION; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE A2; VASOCONSTRICTION;

EID: 33745811692     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2006.03.004     Document Type: Article

References (47)

1. Braquet P., Touqui L., Shen T.Y., and Vargaftig B.B. Perspective in platelet-activating factor research. Pharmacol Rev 39 (1987) 97-145
2. Samuelsson B., Goldyne M., Granstrom E., Hamberg M., Hammarstrom S., and Malmsten C. Prostaglandins and thromboxanes. Ann Rev Biochem 47 (1978) 997-1029
3. Hagmann W., Hacher H.J., and Buchholz U. Resident mast cells are the main initiators of anaphylactic leukotriene production in the liver. Hepatology 16 (1992) 1477-1484
4. Shibamoto T., Ruan Z., Cui S., Liu W., and Kurata Y. Involvement of platelet-activating factor and leukotrienes in anaphylactic segmental venoconstriction in ovalbumin sensitized guinea pig livers. Prostaglandins Other Lipid Mediat 78 (2005) 218-230
5. Guarner F., Wallace J.L., MacNaughton W.K., Ibbotson G.C., Arroyo V., and Rodes J. Endotoxin-induced ascites formation in the rat: partial mediation by platelet-activating factor. Hepatology 10 (1989) 788-794
6. 2 receptor in hepatic sinusoidal endothelial cells and its role in endotoxin-induced liver injury in rats. Hepatology 20 (1994) 1281-1286
7. Tiegs G., and Wendel A. Leukotriene-mediated liver injury. Biochem Pharmacol 37 (1988) 2569-2573
8. Ishiguro S., Arii S., Monden K., et al. Involvement of thromboxane A2-thromboxane A2 receptor system of the hepatic sinusoid in pathogenesis of cold preservation/reperfusion injury in the rat liver graft. Transplantation 59 (1995) 957-961
9. Iwazaki S., Takeyoshi I., Ohawada S., et al. FR128998 ameliorates liver injury in extended liver resection with ischemia in dogs. Hepatogastroenterology 48 (2001) 197-202
10. Takeyoshi I., Sunose Y., Iwazaki S., et al. The effect of a selective cycloxygenase-2 inhibitor in extended liver resection with ischemia in dogs. J Surg Res 100 (2001) 25-31
11. Shimada M., Matsumata T., Taketomi A., Shirabe K., Yamamoto K., and Sugimachi K. The role of prostaglandins in hepatic resection. Prostaglandins Leukot Essent Fatty Acids 50 (1994) 65-68
12. Chun K., Zhang J., Biewer J., Ferguson D., and Clemens M.G. Microcirculatory failure determines lethal hepatocyte injury in ischemic/reperfusion rat livers. Shock 1 (1994) 3-9
13. Fisher R.A., Robertson S.M., and Olson M.S. Stimulation of glycogenolysis and vasoconstriction in the perfused rat liver by the thromboxane A2 analogue U-46619. J Biol Chem 262 (1987) 4631-4638
14. Haussinger D., Stehle T., and Gerok W. Effects of leukotrienes and the thromboxane A2 analogue U-46619 in isolated perfused rat liver. Metabolic, hemodynamic and ion-flux responses. Biol Chem 369 (1988) 97-107
15. Hines K.L., Braillon A., and Fisher R.A. PAF increases hepatic vascular resistance and glycogenolysis in vivo. Am J Physiol 260 (1991) G471-G480
16. Buxton D.B., Fisher R.A., Hanahan D.J., and Olson M.S. Platelet-activating factor mediated vasoconstriction and glycogenolysis in the perfused rat liver. J Biol Chem 261 (1986) 644-649
17. 2 analogue contracts predominantly the hepatic veins in isolated canine livers. Prostaglandins 52 (1996) 483-495
18. Wang H.G., Shibamoto T., and Koyama S. Effect of platelet-activating factor on hepatic capillary pressure in isolated dog liver. Prostaglandins Leukot Essent Fatty Acids 57 (1997) 293-298
19. 2 on isolated perfused guinea pig liver. Prostaglandins Other Lipid Mediat 73 (2004) 73-85
20. Yamaguchi Y., Shibamoto T., Hayashi T., Saeki Y., and Tanaka S. Hepatic vascular response to anaphylaxis in isolated canine liver. Am J Physiol 267 (1994) R268-R274
21. Cui S, Shibamoto T, Ruan Z, Takano H, Liu W, Kurata Y. Oxygen consumption, assessed with the oxygen absorption spectrophotometer, decreases independently of venoconstriction during hepatic anaphylaxis in perfused rat liver. Shock; in press.
22. Shibamoto T., Cui S., Ruan Z., Liu W., Takano H., and Kurata Y. Hepatic venoconstriction is involved in anaphylactic hypotension in rats. Am J Physiol Heart Circ Physiol 289 (2005) H1436-H1441
23. Shibamoto T., Wang H.G., Miyahara T., Tanaka S., Haniu H., and Koyama S. Presinusoidal vessels predominantly contract in response to norepinephrine, histamine, and KCl in rabbit liver. J Appl Physiol 87 (1999) 1404-1412
24. Rothe C.F. Mean circulatory filling pressure: its meaning and measurement. J Appl Physiol 74 (1993) 499-509
25. Lautt W.W., and Legare D.J. Effect of histamine, norepinephrine, and nerves on vascular pressures in dog liver. Am J Physiol 252 (1987) G472-G478
26. Shibamoto T., Narushima M., Ling Y.Q., et al. Different hepatic vascular response to norepinephrine and histamine between guinea pig and rat. Acta Physiol Scand 180 (2004) 255-263
27. Greenway C.V., and Lautt W.W. Effects of infusions of catecholamines, angiotensin, vasopressin and histamine on hepatic blood volume in the anaesthetized cat. Br J Pharmacol 44 (1972) 177-184
28. Bohlen H.G., Maass-Moreno R., and Rothe C.F. Hepatic venular pressures of rats, dogs, and rabbits. Am J Physiol 261 (1991) G539-G547
29. Shibamoto T., Wang H.G., Tanaka S., and Koyama S. Hepatic capillary pressure is estimated using triple vascular occlusion method in isolated canine liver. Am J Physiol 271 (1996) R1130-R1141
30. Shibamoto T., Cui S., Ruan Z., and Kurata Y. Effects of norepinephrine and histamine on vascular resistance in isolated perfused mouse liver. Jpn J Physiol 55 (2005) 143-148
31. Kemp S.F., and Lockey R.F. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110 (2002) 341-348
32. Foster A., Letts G., Charleson S., Fitzsimmons B., Blacklock B., and Rokach J. The in vivo production of peptide leukotrienes after pulmonary anaphylaxis in the rat. J Immunol 141 (1988) 3544-3550
33. Bazzoni G., Beltran N.A., Mascellani G., Bianchini P., Dejana E., and Del Maschio A. Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions. J Lab Clin Med 121 (1993) 268-275
34. Khuri S.F., Valeri C.R., Loscalzo J., et al. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 60 (1995) 1008-1014
35. Wake K. Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs. Int Rev Cytol 66 (1980) 303-353
36. Rockey D.C. Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin Liver Dis 21 (2001) 337-349
37. McCuskey R., Ito Y., McCuskey M., et al. Morphological mechanism for regulating blood flow through hepatic sinusoids: 1998 update and overview. In: Wisse E., Knock D., and De Zanger R. (Eds). Cell of the hepatic sinusoid (1999), Kupffer Cell Foundation, Rijswijk 129-134
38. Ekataksin W., and Kaneda K. Liver microvascular architecture: an insight into the pathophysiology of portal hypertension. Semin Liver Dis 19 (1999) 359-382
39. Soifer S.J., Schreiber M.D., and Heymann M.A. Leukotriene antagonists attenuate thromboxane-inducible pulmonary hypertension. Pediatr Res 26 (1989) 83-87
40. 2 receptor agonist (U-46619)-induced angina in the rat. Eur J Pharmacol 250 (1993) 189-191
41. 2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and l-α-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathway. Biochem J 245 (1987) 145-150
42. 4 and platelet-activating factor on human alveolar macrophage eicosanoid and PAF synthesis. Am Rev Respir Dis 148 (1993) 682-688
43. Bochnwicz S., and Underwood D.C. Dose-dependent mediation of leukotriene D4-induced airway microvascular leakage and bronchoconstriction in the guinea pig. Prostaglandins Leukot Essent Fatty Acids 52 (1995) 403-411
44. 2 analogue U-46619 in isolated perfused rat liver. Biol Chem 369 (1988) 97-107
45. 2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. Biochem J 249 (1988) 677-685
46. Kimura K., Moriyama M., Nishisako M., et al. Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo. J Biochem (Tokyo) 123 (1998) 142-149
47. Rothe C.F., and Maass-Moreno R. Active and passive liver microvascular responses from angiotensin, endothelin, norepinephrine, and vasopressin. Am J Physiol Heart Circ Physiol 279 (2000) H1147-H1156